Works cited by this work

186 works

Work: Hypoxia‐Inducible Factors as Guardians of Cancer Stem Cell Fate: Implications for Novel Therapies

Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning +7
Article20248 citations
ABI
Prospective identification of tumorigenic breast cancer cells
Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández +2
Article20037 citations
ABI
The role of regulatory T cells in the pathogenesis and treatment of prostate cancer
Vahid Karpisheh, Seyedeh Mahboubeh Mousavi, Parinaz Naghavi Sheykholeslami +6
Review article20216 citations
ABI
Cancer stem cells: landscape, challenges and emerging therapeutic innovations
Haksoo Lee, Byeongsoo Kim, Junhyeong Park +7
Review article20256 citations
ABI
Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells
Mehrdad Fathi, Simin Bahmanpour, Asal Barshidi +12
Article20215 citations
ABI
Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer
Vahid Karpisheh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi +7
Review article20195 citations
ABI
EP4 receptor as a novel promising therapeutic target in colon cancer
Vahid Karpisheh, Navneet Joshi, Angelina Olegovna Zekiy +5
Review article20205 citations
ABI
The role of Th17 cells in the pathogenesis and treatment of breast cancer
Vahid Karpisheh, Majid Ahmadi, Kazem Abbaszadeh‐Goudarzi +5
Review article20225 citations
ABI
The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha
Mohammad Reza Sadeghi, Asma Moslehi, Hadiseh Kheiry +11
Article20245 citations
ABI
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Zhou Chen, Fangfang Han, Yan Du +2
Review article20235 citations
ABI
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Review article20235 citations
ABI
Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles
Abbas Ali Hosseinpour Feizi, Sajjad Vakili‐Samiani, Vahid Karpisheh +11
Article20224 citations
ABI
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide
Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13
Article20234 citations
ABI
RETRACTED: Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli +11
Article20214 citations
ABI
Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art
Zahra Hatami, Zahra Sadat Hashemi, Mohamad Eftekhary +4
Review article20234 citations
ABI
The molecular biology and therapeutic potential of Nrf2 in leukemia
Atefeh Khodakarami, Sara Adibfar, Vahid Karpisheh +6
Review article20224 citations
ABI
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Tsvee Lapidot, Christian Sirard, Josef Vormoor +7
Article19943 citations
ABI
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Brian Keith, Randall S. Johnson, M. Celeste Simon
Review article20113 citations
ABI
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Yin Wang, Yan Liu, Sami N. Malek +2
Article20113 citations
ABI
Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice
Ghasem Ghalamfarsa, Ali Rastegari, Fatemeh Atyabi +11
Article20183 citations
ABI
T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer
Mehrdad Fathi, Inna Pustokhina, Sergey V. Kuznetsov +5
Review article20213 citations
ABI
Pan Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer
Sepideh Izadi, Mohammad Hojjat Farsang, Vahid Karpisheh +1
Article20233 citations
ABI
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1
Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami +13
Article20253 citations
ABI
Cancer stem cells (CSCs) in cancer progression and therapy
Masoud Najafi, Bagher Farhood, Keywan Mortezaee
Review article20183 citations
ABI
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1
Heba Alshaker, Qi Wang, Yoshiaki Kawano +5
Article20162 citations
ABI